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Paget’s disease of bone (PDB) is characterised by the disruption of bone formation and resorption which leads to bone 
deformities. It is considered to be a relatively benign 
bone disease in most cases. The most commonly 
affected sites are the pelvis [Figure 1], femur, tibia, 
lumbar spine and skull; thus, abdominal radiographs 
are often performed to diagnose PDB in people over 
the age of 55 years.1 The disease is more prevalent 
among northern European populations, including 
Scandinavians, and is considered to be uncommon in 
non-Caucasians.1 Randomised trials have shown that 
antiresorptive therapy decreases bone pain and lowers 
alkaline phosphatase levels, which helps to assess the 
extent and severity of the disease in affected patients.2 
The aetiology of PDB is not yet fully understood. 
However, genetics are thought to play a part in the 
disease’s development, with more than 20% of PDB 
patients reporting a first-degree relative with the same 
condition.3 Studies have shown the involvement of 
specific genetic loci, including the colony stimulating 
factor 1, optineurin, transmembrane 7 superfamily 
member 4 and Ras and Rab interactor 3 genes.3,4 
Heterozygous mutations affecting the sequestosome 1 
(SQSTM1) gene, which are clustered in the ubiquitin-
binding domain encoded by exon 7 and 8, have 
been commonly reported among PDB patients.5 
The other type of mutation is less common and 
includes domain-specific defects within valosin-
containing protein which can lead to PDB in a rare 
syndrome associated with dementia and late-onset 
inclusion body myopathy.6 A viral aetiology remains 
controversial, since these observations have not always 
been replicated and thus far, viruses have not been 
isolated from pagetoid tissue.7
As the prevalence of PDB has decreased in certain 
countries over the past 25 years, it has been suggested 
that environmental factors may be important in 
the development of PDB.8 However, additional 
research addressing the environmental impact on 
the development of PDB is required. The highest 
prevalences of PDB are found in Britain, Australia, 
New Zealand, North America, western Europe and 
among Caucasians over the age of 50 years.9,10
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االأوروبية، ومن  �ضائع بني �ضكان املناطق  ن�ضبيًا  وهو  الحميدة  األمر�س  من   )PDB( العظام  الذي ي�ضيب  مر�س باجيت  يعد  امللخ�ص: 
�ضمنها �ضكان اململكة املتحدة واإيطاليا واإ�ضبانيا. ومع ذلك فهو نادراً ما يظهر بني اال�ضكندنافيني واملهاجرين من اأ�ضول غري اأوروبية 
الذين يعي�ضون يف اأوروبا. وقد يكون تقدير  انت�ضار هذا املر�س بني �ضكان اآ�ضيا  اأقل كثريا مما هو يف الواقع ب�ضبب اأن عددا كبريا من 
احلاالت  امل�ضجلة  كان اكت�ضافها م�ضادفة. اإن هنالك حاجة الإجراء درا�ضات ا�ضتق�ضائية لدرا�ضة معدل انت�ضار ونتائج االإ�ضابة مبر�س 
باجيت التي ال بد من معرفتها واالأخذ بها يف اأجزاء خمتلفة من العامل، وخا�ضة اآ�ضيا.
مفتاح الكلمات: مر�س باجيت الذي ي�ضيب العظام؛ املجموعات العرقية؛ علم االأوبئة.
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Although this disease is generally not seen in 
non-European populations, a case series reported 
eight non-Caucasian PDB patients in East London 
in the UK.14 Two of the patients were of Bangladeshi 
origin and both died of complications; one had an 
angiosarcoma and the other had an osteosarcoma. 
Both patients were male and relatively young (63 and 
58 years old).15
Similar PDB prevalence rates were found in a 
survey of 13 different European towns across nine 
countries (2–3%), except for Sweden which showed 
a much lower prevalence (0.4%) [Table 1].16 In Italy, 
the overall rate of PDB was found to range between 
0.7–2.4%.17 A recent study demonstrated that the 
incidence of PDB in two regions of Spain had stayed 
the same over the past 24 years, although the severity 
of the disease had declined.18 Campagnia, Italy, and 
Vitigudino, Spain, are also known to have a high 
prevalence of PDB.19
north america
In the USA, approximately 1% of the population are 
affected by PDB, with the north-eastern region of 
the USA showing the highest prevalence.20 Although 
the disease is thought to be rare in non-Caucasian 
populations, research has indicated that there is no 
difference in prevalence between Caucasians and 
African-Americans.21 A survey carried out in New 
York City, New York, and Atlanta, Georgia, revealed 
that while there was a different prevalence between 
the two cities, there was a similar prevalence between 
the two ethnic groups [Table 2].20
australia and new zealand 
PDB is also common in Australia and New Zealand, 
with a prevalence of approximately 4%.21,22 In one 
study, the prevalence was found to be higher among 
British migrants coming to Australia than among 
the Australian residents.21 Recent evidence suggests 
a decrease in the prevalence rate and severity of 
the disease in New Zealand.22 A study of the Asian 
population in Auckland, New Zealand, showed nearly 
the same prevalence of PDB as in people of European 
origin.23 This finding suggests that the low prevalence 
Prevalence in Various Regions 
europe
PDB is common in Caucasians, although the disease 
rarely occurs among individuals below 50 years old.1 
It has been found that the rate of PDB increases 
significantly in those over 90 years of age.11 Within the 
UK, the prevalence of this condition appears to have 
decreased over recent years. In a study conducted in 
1980, it was found that the north-western Lancashire 
towns of Preston, Bolton, Wigan, Burnley and 
Blackburn had an average PDB prevalence of 6.8%, 
while Lancaster had the highest prevalence rate at 
8.3%.12 However, a more recent study conducted in 
England and Wales revealed a total prevalence of 0.3% 
among men and women aged 55 years and above.13 
This suggests a dramatic decline in the PDB prevalence 
in the UK.
Table 1: Age- and sex-standardised prevalence of 
Paget’s disease of bone among hospital patients aged 
≥55 years in various European towns16














*Prevalence calculated from 31 towns in the UK.
Table 2: Age-standardised prevalence of Paget’s disease 
of bone in African-American and Caucasian residents 





New York African 3.3 2.0 2.6
New York Caucasian 5.2 2.5 3.9
Atlanta African 1.9 0.6 1.2
Atlanta Caucasian 0.9 0.8 0.9
Figure 1: Radiograph of the pelvis of a 73-year-old 
patient originally from Sierra Leone with widespread 
Paget’s disease of the bone.
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of PDB in Asia, as discussed later on in this review, 
might be underestimated due to a lack of awareness 
among physicians. 
africa
PDB is also common in South Africa. A survey of 
abdominal radiographs from 1,003 South Africans of 
European descent and 1,355 South Africans of African 
descent who were 55 years or older, showed prevalence 
rates of 2.4% and 1.3%, respectively.24 The disease 
prevalence varies in other regions of Africa; however, 
it is generally rare. A study of 82,000 radiographs 
collected over four years in Freetown, Sierra Leone, 
revealed only 14 cases of PDB, while no documented 
case was detected over the same period and number of 
radiographs in northern Nigeria.25 Research has shown 
that this disease is also rare in sub-Saharan Africa.25
asia
In Asia, PDB is known to be rare; however, there 
are reported cases among Chinese patients.26–28 In 
Singapore, five cases of PDB were found over an eight-
year period.29 This series included a 72-year-old Indian 
patient whose diagnosis of PDB was made incidentally 
after he had suffered an ischaemic stroke. A computed 
tomography scan of the head revealed bony changes in 
the skull consistent with PDB and his serum alkaline 
phosphatase levels were also elevated.29 There have 
been other reported cases of PDB among Indians, 
although its true prevalence in the Indian population 
is suspected to be higher, as most cases are discovered 
incidentally.30,31 
As mentioned previously, research has indicated 
a similar prevalence of PDB between individuals of 
Asian and those of European origin,23 indicating that 
this disease is under-recognised in Asia. Furthermore, 
a review of PDB among the ethnic Thai population 
theorised that the prevalence of this disorder will 
increase in the future due to the increasing number 
of Asian-European intermarriages.32 Thus, it is 
imperative that healthcare workers in Asia increase 
their awareness of PDB and its symptoms in order to 
provide effective care for their patients. 
south america
In South America, PDB is generally present 
among those of European descent, with research 
demonstrating that the disease is not present within 
the indigenous population.33 The incidence is relatively 
high in Argentina, especially around Buenos Aires, 
which has a large population of Spanish and Italian 
immigrants. It occurs less frequently in Chile and 
Venezuela, both of which have fewer citizens of 
European descent.33 However, a pilot epidemiological 
study conducted in the city of Recife, in north-east 
Brazil, found a similar PDB prevalence (6.8 per 1,000 
people) and incidence (50.3 per 10,000 person-years) 
as that noted in southern Europe.34
the middle east
A survey conducted in southern Israel from 1968–
1993 yielded 61 cases of PDB and indicated a 
prevalence of approximately 1%, which is close to that 
found in southern Europe.35 The majority of these 
cases were patients of Afro-Asian descent (56%), with 
the remaining 44% of Afro-Asian origin. Israel was 
the country of origin for few of the identified PDB 
patients; Romania, Tunisia, Australia and Argentina 
were the most frequent countries of origin. All of 
the patients were Jewish with the exception of one 
Bedouin Arab.35 In another study carried out between 
1961 and 1985 in four medical centres in Israel, 278 
cases of PDB were identified in Jewish patients.36 Only 
six of these patients were immigrants, of which 74% 
were originally from Eastern Europe. There were no 
patients of Arab ethnicity included in the 278 studied 
PDB cases.36 
There have been isolated cases of PDB reported 
in Saudi Arabia, Iran, Iraq and Turkey.37–40 Although, 
to the best of the authors’ knowledge, no cases of 
PDB in Egypt, Lebanon or Syria have been published, 
there are verbal reports from rheumatologists in these 
countries about isolated cases of PDB in the local Arab 
populations.
Recommendations for Future 
Research
It is difficult to be certain of the exact prevalence of 
PDB among various ethnic groups due to the small 
sample sizes used in many studies. Based on the 
available research, PDB appears to be comparatively 
rare in Asian and African populations. However, it is 
very likely that this disease is under-reported in these 
populations, especially given the lack of prevalence 
studies in Asian and African countries. There is no 
clear explanation for the high PDB prevalence in 
Lancashire, UK, but the fact that this area has a high 
proportion of immigrants who are Asian in origin 
may be significant.12 Therefore, there is a need to 
conduct epidemiological studies aimed at estimating 
the prevalence of the disease among Asians and 
Caucasians. Further studies should seek to investigate 
the true prevalence and incidence of PDB in various 
regions of the world. 
The overall prevalence of this disease has 
decreased by 36% over the last 19 years.41 This decline 
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is mostly attributed to environmental rather than 
genetic factors.41 However, while significant progress 
has been made in the identification of the exact genetic 
mutations associated with PDB, further research 
is needed to determine the precise environmental 
factors involved. 
Conclusion
PDB appears to be more common among Europeans 
and rare among Asian and African populations. 
However, cases of PDB in Africa and Asia are likely 
under-reported, resulting in a need for further 
epidemiological studies to assess the true incidence 
of this disease in both Caucasian and non-Caucasian 
populations. Considerable progress has been made 
regarding the genetic factors associated with PDB. 
However, it is theorised that environmental factors 
contribute greatly to the development of this condition. 
Future research is therefore recommended in this area.
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